Adaptive Biotechnologies
Mary Pat Lancelotta is an accomplished executive with extensive experience in the biotech and life sciences industries. Currently serving as SVP of BioPharma and SVP of Corporate Affairs and Communications at Adaptive Biotechnologies Corp. since January 2019, Mary Pat has also held roles as Vice President of Corporate Marketing and Communications. In addition, Mary Pat is a board member at MolecularMatch and previously at Ultivue. A former Senior Vice President of Commercial Operations at Lumicell and Vice President of Strategic Marketing at Foundation Medicine, Mary Pat has driven significant innovation and market growth, particularly in the development and launch of clinical molecular assays. Earlier career highlights include leadership positions at Quest Diagnostics and consulting roles at The Frankel Group and AT Kearney. Mary Pat holds an MBA in Marketing and Management from Columbia Business School and a BS in Biochemistry, Magna Cum Laude, from Boston College.
This person is not in any offices
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.